Hypoxia Induces Production of L-2-Hydroxyglutarate.
Hypoxia Induces Production of L-2-Hydroxyglutarate.
复制标题
DOI:
10.1016/j.cmet.2015.06.023
复制
发表时间:
2015-08-04
期刊:
影响因子:
29
通讯作者:
Thompson CB
中科院分区:
文献类型:
--
作者:
Intlekofer AM;Dematteo RG;Venneti S;Finley LW;Lu C;Judkins AR;Rustenburg AS;Grinaway PB;Chodera JD;Cross JR;Thompson CB
Somatic mutations in isocitrate dehydrogenase 1 or 2 (IDH1/2) contribute to the pathogenesis of cancer via production of the ‘oncometabolite’ D-2-hydroxyglutarate (D-2HG). Elevated D-2HG can block differentiation of malignant cells by functioning as a competitive inhibitor of alpha-ketoglutarate (α-KG)-dependent enzymes, including Jumonji family histone lysine demethylases. 2HG is a chiral molecule that can exist in either the D- or L- enantiomer. Although cancer-associated IDH1/2 mutations produce D-2HG, biochemical studies have demonstrated that L-2HG also functions as a potent inhibitor of α-KG-dependent enzymes. Here we report that under conditions of oxygen limitation, mammalian cells selectively produce L-2HG via enzymatic reduction of α-KG. Hypoxia-induced L-2HG is not mediated by IDH1 or IDH2, but instead results from promiscuous substrate usage primarily by lactate dehydrogenase A (LDHA). During hypoxia, the resulting increase in L-2HG is necessary and sufficient for the induction of increased methylation of histone repressive marks, including histone 3 lysine 9 (H3K9me3).